Peanut Consumption on Cognitive, Weight, and Inflammation
PEANUTY
1 other identifier
interventional
200
1 country
1
Brief Summary
A multi-school, two-arm parallel cluster-randomized controlled trial will be conducted in 200 healthy young adolescents from Barcelona (Spain) to evaluate the effect of peanut consumption on cognitive performance, weight management and inflammation. Schools willing to participate will be randomly assigned to either the intervention or the control group. After the recruitment, the participants will follow a peanut-free diet for two weeks. Both arms will receive a multidimensional educational intervention designed by the Gasol Foundation to promote healthy dietary habits based on Mediterranean diet recommendations, along with exercise performance, healthy sleeping habits and emotional knowledge. Half of the participants (intervention group) will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2023
CompletedFirst Posted
Study publicly available on registry
November 13, 2023
CompletedStudy Start
First participant enrolled
January 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 3, 2025
March 1, 2025
1.4 years
October 31, 2023
March 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Changes in the depression score in healthy young adolescents after a daily intake of peanuts.
To measure depression score, the CDI Childhood Depression Inventory test will be used.
Baseline and after 6 months
Changes in the ability to concentrate, selective attention and processing speed in healthy young adolescents after a daily intake of peanuts.
To measure the ability to concentrate, selective attention and processing speed, the d2-R Attention Test (Revised) will be used.
Baseline and after 6 months
Changes in assessment of interference and cognitive control in healthy young adolescents after a daily intake of peanuts.
To measure the assessment of interference and cognitive control, the Stroop test will be used.
Baseline and after 6 months
Changes in processing speed, attention span and working memory in healthy young adolescents after a daily intake of peanuts.
To measure processing speed, attention span and working memory, the WISC-V Digits and Codes Subtest will be used.
Baseline and after 6 months
Changes in attention and inductive reasoning in healthy young adolescents after a daily intake of peanuts.
To measure in attention and inductive reasoning, the Raven-2 test will be used.
Baseline and after 6 months
Changes in Social cognition (emotion recognition and theory of mind) in healthy young adolescents after a daily intake of peanuts.
To measure Social cognition (emotion recognition and theory of mind), the NEPSY-II subtest will be used.
Baseline and after 6 months
Changes in pro- and anti-inflammatory biomarkers after a daily intake of peanuts in healthy young adolescents.
Cytokines (pg/mL), Monocyte chemoattractant protein-1 (MCP-1) (pg/mL), interleukin (IL)-6 and 10 (pg/mL), (mg/dL) will be assayed by immunoenzymatic methods.
Baseline and after 6 months
Changes in vascular biomarkers after a daily intake of peanuts in healthy young adolescents.
sVCAM-1 and sICAM-1 (ug/mL) will be assayed by immunoenzymatic methods.
Baseline and after 6 months
Changes in adiposity molecules after a daily intake of peanuts in healthy young adolescents
Adiponectin and adipsin (ug/mL), leptin (pg/mL), ghrelin (pg/mL), visfatin (pg/dL), resistin (pg/mL), insulin (pg/mL), glucagon (pg/dL), peptid C (pg/mL) and, PAI-1 (pg/mL) will be assayed by immunoenzymatic methods.
Baseline and after 6 months
Changes in body mass index after a daily intake of peanuts in healthy young adolescents
Body mass index (kg/m\^2) are calculated after measure weight (kg) and height (meter).
Baseline, 3 and after 6 months
Secondary Outcomes (13)
Changes in waist circumference after a daily intake of peanuts in healthy young adolescents
Baseline, 3 and after 6 months
Changes in blood pressure after a daily intake of peanuts in healthy young adolescents
Baseline, 3 and after 6 months
Changes in heart rate after a daily intake of peanuts in healthy young adolescents
Baseline, 3 and after 6 months
Changes in lipidic profile after a daily intake of peanuts in healthy young adolescents
Baseline and after 6 months
Changes in blood glucose after a daily intake of peanuts in healthy young adolescents
Baseline and after 6 months
- +8 more secondary outcomes
Study Arms (2)
Peanuty group
EXPERIMENTALFamilies allocated in the intervention group will receive the whole skin roasted peanuts packed in daily doses (25 g per day, 750 g per month), starting the day that we will visit the participants for the first time. They will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.
Control group
NO INTERVENTIONUsual care
Interventions
After the recruitment, the participants will follow a peanut-free diet for two weeks.
Eligibility Criteria
You may qualify if:
- Eligible participants will be young adolescents, boys and girls, aged between 10 and 12 years who attend regular primary schools in Barcelona. The schools will assist with the participant recruitment through the classes and after that, a total of one-hundred students will be randomly included in each group. In all cases, participation will be voluntary and informed consent will be obtained prior to the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Barcelonalead
- Gasol Foundationcollaborator
- Universitat Oberta de Catalunyacollaborator
- Institut d'Investigacions Biomèdiques August Pi i Sunyercollaborator
Study Sites (1)
IDIBAPS
Barcelona, Barcelona, 08036, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 31, 2023
First Posted
November 13, 2023
Study Start
January 29, 2024
Primary Completion
June 30, 2025
Study Completion
December 31, 2025
Last Updated
April 3, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
The dataset analyzed during the current study is not publicly available due to national data regulations and for ethical reasons, e.g. we do not have the explicit written consent of the study volunteers to make their deidentified data available at the end of the study. However, data described in the manuscript, codebook, and analytic codes will be made available upon request by contacting the PI and Co-PI (peanuty2023@gmail.com). The request will be passed to all the members of the study for deliberation.